monoclonal antibodies inhibit prion replication delay development prion disease 
prion diseases creutzfeldt-jakob disease cjd fatal neuro-degenerative disorders known therapy proportion uk population exposed bovine spongiform encephalopathy-like prion strain- risk developing variant cjd hallmark prion disease transformation normal cellular prion protein prpc infectious disease-associated isoform prpsc recent vitro studies indicate anti-prp monoclonal antibodies little affinity prpsc can prevent incorporation prpc propagating prions therefore investigated murine scrapie model whether anti-prp monoclonal antibodies show similar inhibitory effects prion replication vivo found peripheral prpsc levels prion infectivity markedly reduced even antibodies first administered point near maximal accumulation prpsc spleen furthermore animals treatment continued remained healthy days equivalent untreated animals succumbed disease findings indicate immunotherapeutic strategies human prion diseases worth pursuing 
